An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 26, 2019

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2024

Conditions

Tobacco Use Disorder

Interventions

DRUG

Clavulanic Acid

Beta lactamase inhibitor for smoking cessation

DRUG

Placebo oral capsule

placebo

Trial Locations (1)

RECRUITING

University of Missouri - Columbia, Columbia

All Listed Sponsors

lead

University of Missouri-Columbia

OTHER